RESistance Under Combinatorial Treatment in ER+ and ER- Breast Cancer


The RESCUER consortium consists of fifteen organizations from ten different countries (Belgium, Finland, France, Germany, Israel, Norway, Spain, Sweden, United Kingdom, United States) and gathers all the relevant expertise and facilities to solve the challenge of identifying novel characterization methods for breast cancer drug resistance and new knowledge on effective combinatorial treatments.



29 Jan.

Subscribe to our newsletters